Mouse Anti-Human TIE-2

Slide this table

Cat-Nr.101-M54
Size100 µg
Price230 €
CategoryMonoclonal Antibody
Clone Nr.(#tek16)
IsotypeIgG1
Species ReactivityHuman
Formulationlyophilized
BufferPBS
ReconstitutionCentrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 1.0 mg/ml.
Stability and StorageThe lyophilized antibody is stable at room temperature for up to 1 month. The reconstituted antibody is stable for at least two weeks at 2-8 °C. Frozen aliquots are stable for at least 6 months when stored at -20 °C.
PreparationThe monoclonal antibody was produced with the help of BALB/c mice using recombinant human soluble extracellular TIE-2 as the immunizing antigen. Mouse IgG1 antibody (#tek16) from hybridomas was purified from cell culture supernatant by Protein G chromatography.
Antigenrecombinant human soluble extracellular TIE-2
ApplicationELISA, WB, FC
SynonymsTEK; TIE2; VMCM; TIE-2; VMCM1; CD202B
DescriptionTie-1/Tie and Tie-2/Tek are receptor tyrosine kinases with unique structural characteristics including two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains, followed by three fibronectin type III-like repeats in the extracellular region, and a split tyrosine kinase domain in the cytoplasmic region. Tie-2 is involved in vascular stabilization and remodeling. Although less well understood, Tie-1 may also act as an ANG receptor, possibly in complex with Tie-2. Human Tie-2 cDNA encodes a 1124 amino acid (aa) residue precursor protein with an 18 residue putative signal peptide, a 727 residue extracellular domain and a 354 residue cytoplasmic domain. Tie-2 is a receptor for the angiopoietin (ANG) family: ANG-1, ANG-2, and ANG-3 (mouse)/-4 (human). Ang-2 has been reported to act as an antagonist for Ang-1. Mice engineered to overexpress Ang-2 or to lack Ang-1 or Tie-2 display similar angiogenesis defects.
Uniprot IDQ02763
Protein RefSeqNP_000450.2
mRNA RefSeqNM_000459.3

Figures


Reference

  1. Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII. Shahani T. et al., J Thromb Haemost. 2014 Jan;12(1):36-42.
  2. Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas. S. Norgall et al., BMC Cancer. 2007; 7: 105.
  3. Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Reusch P. et al., Angiogenesis. 2001;4(2):123-31.
  4. Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy. Harris AL et al., Clin Cancer Res. 2001 Jul;7(7):1992-7.

All prices plus VAT + possible delivery charges